These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 39060439

  • 1. Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis.
    Tang X, Gao L, Jiang X, Hou Z, Wang Y, Hou S, Qu H.
    Oncogene; 2024 Aug; 43(35):2635-2646. PubMed ID: 39060439
    [Abstract] [Full Text] [Related]

  • 2. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H, Chen Y, Niu H, Li X, Gai X, Cui G.
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [Abstract] [Full Text] [Related]

  • 3. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
    Liu J, Wu S, Zheng X, Zheng P, Fu Y, Wu C, Lu B, Ju J, Jiang J.
    Sci Rep; 2020 Sep 08; 10(1):14749. PubMed ID: 32901082
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells.
    Xi F, Sun H, Peng H, Lian Z, Wei H, Tian Z, Sun R, Chen Y.
    JCI Insight; 2024 May 23; 9(13):. PubMed ID: 38973608
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DAB2 + macrophages support FAP + fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer.
    Long F, Zhong W, Zhao F, Xu Y, Hu X, Jia G, Huang L, Yi K, Wang N, Si H, Wang J, Wang B, Rong Y, Yuan Y, Yuan C, Wang F.
    Theranostics; 2024 May 23; 14(12):4822-4843. PubMed ID: 39239526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts.
    Shimizu D, Yuge R, Kitadai Y, Ariyoshi M, Miyamoto R, Hiyama Y, Takigawa H, Urabe Y, Oka S.
    Int J Mol Sci; 2024 Jun 26; 25(13):. PubMed ID: 39000110
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D, Doughty-Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, Kitamura T.
    J Immunother Cancer; 2021 Jan 26; 9(1):. PubMed ID: 33472858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    Li H, Han Y, Guo Q, Zhang M, Cao X.
    J Immunol; 2009 Jan 01; 182(1):240-9. PubMed ID: 19109155
    [Abstract] [Full Text] [Related]

  • 13. Resting natural killer cells promote the progress of colon cancer liver metastasis by elevating tumor-derived stem cell factor.
    Mao C, Chen Y, Xing D, Zhang T, Lin Y, Long C, Yu J, Luo Y, Ming T, Xie W, Han Z, Mei D, Xiang D, Lu M, Shen X, Xue X.
    Elife; 2024 Oct 10; 13():. PubMed ID: 39387546
    [Abstract] [Full Text] [Related]

  • 14. Tumor-associated macrophages impair NK cell IFN-γ production and contribute to tumor progression in clear cell renal cell carcinoma.
    Núñez SY, Trotta A, Regge MV, Amarilla MS, Secchiari F, Sierra JM, Santilli MC, Gantov M, Rovegno A, Richards N, Ameri C, Ríos Pita H, Rico L, Mieggi M, Vitagliano G, Blas L, Friedrich AD, Domaica CI, Fuertes MB, Zwirner NW.
    Eur J Immunol; 2024 Jun 10; 54(6):e2350878. PubMed ID: 38581345
    [Abstract] [Full Text] [Related]

  • 15. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
    Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, Li X, Zhou W, Li J, Li Z, Bai C, Zhao L, Han Q, Zhao RC, Wang X.
    Theranostics; 2022 Jun 10; 12(2):620-638. PubMed ID: 34976204
    [Abstract] [Full Text] [Related]

  • 16. The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer.
    Jiang L, Zhao X, Li Y, Hu Y, Sun Y, Liu S, Zhang Z, Li Y, Feng X, Yuan J, Li J, Zhang X, Chen Y, Shen L.
    IUBMB Life; 2024 Jul 10; 76(7):420-436. PubMed ID: 38126920
    [Abstract] [Full Text] [Related]

  • 17. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling.
    Zhang D, Sun R, Di C, Li L, Zhao F, Han Y, Zhang W.
    Comput Biol Med; 2023 Nov 10; 166():107406. PubMed ID: 37729702
    [Abstract] [Full Text] [Related]

  • 18. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
    Bödder J, Zahan T, van Slooten R, Schreibelt G, de Vries IJM, Flórez-Grau G.
    Front Immunol; 2020 Nov 10; 11():631713. PubMed ID: 33679726
    [Abstract] [Full Text] [Related]

  • 19. CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage.
    Wei R, Song J, Pan H, Liu X, Gao J.
    Oncoimmunology; 2024 Nov 10; 13(1):2352179. PubMed ID: 38746869
    [Abstract] [Full Text] [Related]

  • 20. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation.
    Yao L, Hou J, Wu X, Lu Y, Jin Z, Yu Z, Yu B, Li J, Yang Z, Li C, Yan M, Zhu Z, Liu B, Yan C, Su L.
    Redox Biol; 2023 Nov 10; 67():102923. PubMed ID: 37832398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.